drugset / Trial / NCT02236988
Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men
RandomizedCrossoverOpen-labelOther
Summary
This study will assess up to 12 different oral formulations of apremilast to determine how much apremilast is absorbed by the body compared to a reference formulation.
Timeline
- Start
- 2014-01-07
- Primary completion
- 2014-09-11
- Completion
- 2014-09-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Apremilast | Small molecule | 30 mg | Oral |
| Subject | Apremilast | Small molecule | 75 mg | Oral |
| Subject | Apremilast | Small molecule | 80 mg | Oral |
Indications
No indication recorded.